Signature Cord Prime™ Receives Investigational New Drug (IND) Approval from FDA for Phase 1 Study in Patients with Symptomatic Osteoarthritis of the Knee
March 9, 2021
Dallas, Texas., Feb. 16, 2021 /PRNewswire/-– Signature Biologics, LLC., a regenerative medicine company focused on [Read More...]